查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1608127

胰島素輸送設備市場：按產品、最終用戶分類 - 全球預測 2025-2030 年

Insulin Delivery Devices Market by Product (Insulin Injectors, Insulin Pens, Insulin Pumps), End-User (Homecare, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年胰島素輸送設備市值為285.5億美元，預計到2024年將達到306.1億美元，複合年成長率為8.00%，到2030年將達到489.3億美元。

胰島素輸送設備市場包括多種用於注射胰島素給糖尿病患者的產品。這些設備包括注射器、胰島素筆、胰島素幫浦和噴射注射器，每種設備都滿足不同的患者需求和偏好。由於人口老化、生活方式的改變和肥胖率的增加，全球糖尿病盛行率不斷上升，推動了對此類設備的需求。胰島素輸送設備用於管理第 1 型和第 2 型糖尿病，最終用戶是個人、醫療保健提供者和醫院。該市場的成長是由於人們對糖尿病管理的認知不斷提高、提高患者便利性的設備設計技術進步以及對家庭醫療保健解決方案的日益關注而推動的。新的商機在於擴大採用將智慧胰島素筆和胰島素幫浦與連續血糖監測結合的閉合迴路系統。這些創新將顯著改善血糖控制，並為市場相關人員創造重大商機。然而，高成本、有限的報銷政策以及先進設備的安全問題等挑戰正在阻礙市場擴張。此外，新設備核准方面的監管障礙也是一個障礙。儘管存在這些挑戰，市場仍提供了巨大的創新潛力，特別是在人工智慧和機器學習的整合以進行胰島素劑量的預測分析方面。擴大與數位健康平台的連接也可以開闢新的業務途徑。研究的重點是提高設備的可用性和提高胰島素輸送系統的準確性。奈米遞送技術和生物整合設備的進步有可能進一步改變患者的依從性和結果。由於市場參與企業必須透過以患者為中心的解決方案進行創新才能持續成長，競爭仍在繼續。分析當地醫療保健政策、患者人口統計數據，並與醫療機構合作進行大規模試驗，為獲取和擴大市場佔有率提供可操作的見解，確保全面了解並有效回應患者需求。

主要市場統計
基準年[2023] 285.5億美元
預計年份 [2024] 306.1億美元
預測年份 [2030] 489.3億美元
複合年成長率（%） 8.00%

市場動態：揭示快速發展的胰島素輸送設備市場的關鍵市場洞察

供需的動態交互作用正在改變胰島素輸送設備市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 慢性病的增加及先進胰島素輸送設備的採用
    • 世界各地糖尿病和肥胖人口不斷增加
    • 提高消費者對現代胰島素輸送設備的認知
  • 市場限制因素
    • 胰島素輸送設備高成本且缺乏保險
  • 市場機會
    • 胰島素輸送裝置的技術進步
    • 自動胰島素輸送裝置簡介
  • 市場挑戰
    • 嚴格的政府法規和複雜的產品核可流程

波特五力：駕馭胰島素輸送設備市場的策略工具

波特的五力框架是了解胰島素輸送設備市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解胰島素輸送設備市場的外部影響

外部宏觀環境因素在塑造胰島素輸送設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解胰島素輸送設備市場的競爭格局

胰島素輸送設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣胰島素輸送設備市場供應商的績效評估

FPNV定位矩陣是評估胰島素輸送設備市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了胰島素輸送設備市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，胰島素輸送設備市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病的增加及先進胰島素管理設備的引進
      • 糖尿病和肥胖症在世界範圍內呈上升趨勢
      • 消費者對現代胰島素輸送設備的認知不斷增強
    • 抑制因素
      • 胰島素輸送裝置成本高且保險範圍有限
    • 機會
      • 胰島素輸送裝置的技術進步
      • 自動胰島素輸送裝置簡介
    • 任務
      • 更嚴格的政府法規和更複雜的產品核可流程
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章胰島素輸送設備市場：依產品

  • 胰島素注射器
  • 胰島素筆
  • 胰島素幫浦
  • 胰島素注射器

第7章胰島素輸送設備市場：依最終用戶分類

  • 居家護理
  • 醫院

第 8 章美洲胰島素輸送設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太胰島素輸送設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的胰島素輸送設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Baxter International Inc
  • Becton, Dickinson and Company
  • Biocon Ltd.
  • Braun Melsungen AG
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company, Ltd.
  • Dr Reddy's Laboratories Ltd
  • Eli Lilly and Company
  • F. Hoffmann-La Roche, Ltd.
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Sanofi SA
  • Tandem Diabetes Care, Inc.
  • TOPAS Advanced Polymers GmbH
  • Ypsomed AG
  • Zealand Pharma A/S
Product Code: MRR-ED54C46E8A4A

The Insulin Delivery Devices Market was valued at USD 28.55 billion in 2023, expected to reach USD 30.61 billion in 2024, and is projected to grow at a CAGR of 8.00%, to USD 48.93 billion by 2030.

The insulin delivery devices market encompasses a wide range of products designed to administer insulin to individuals with diabetes. These devices include syringes, insulin pens, insulin pumps, and jet injectors, each catering to different patient needs and preferences. The necessity for such devices stems from the global rise in diabetes prevalence, compounded by aging populations, lifestyle changes, and increasing obesity rates. Insulin delivery devices are employed in both Type 1 and Type 2 diabetes management, with end-users comprising individuals, healthcare providers, and hospitals. Growth in this market is driven by heightened awareness of diabetes management, technological advancements in device design enhancing patient convenience, and a stronger focus on home healthcare solutions. Emerging opportunities lie in the increasing adoption of smart insulin pens and closed-loop systems that integrate continuous glucose monitoring with insulin pumps. These innovations can significantly enhance glycemic control, presenting substantial opportunities for market players. However, challenges such as high costs, limited reimbursement policies, and safety concerns of advanced devices hamper market expansion. Additionally, regulatory hurdles for new device approvals pose barriers. Despite these challenges, the market offers significant potential for innovation, particularly in the integration of artificial intelligence and machine learning for predictive analytics in insulin administration. Expanding device connectivity with digital health platforms can also offer new business avenues. Research can focus on enhancing the user-friendliness of devices and improving the precision of insulin delivery systems. Advancements in nano-delivery technologies and biologically integrated devices may further revolutionize patient adherence and outcomes. The market remains competitive, with participants needing to align innovations with patient-centric solutions to continue fostering growth. Analyzing regional healthcare policies, patient demographics, and collaborating with healthcare facilities for large-scale trials can provide actionable insights into capturing and expanding market shares, ensuring a comprehensive understanding and addressing patient needs effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 28.55 billion
Estimated Year [2024] USD 30.61 billion
Forecast Year [2030] USD 48.93 billion
CAGR (%) 8.00%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Insulin Delivery Devices Market

The Insulin Delivery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing chronic diseases and adoption of advanced devices for insulin delivery
    • Increasing diabetic & obese population across the globe
    • Rising consumer awareness about the latest insulin delivery devices
  • Market Restraints
    • High cost of insulin delivery devices and lack of insurance coverage
  • Market Opportunities
    • Technological advancements in insulin delivery devices
    • Introduction of automated insulin delivery devices
  • Market Challenges
    • Increasing stringent government rules and complicated product approval process

Porter's Five Forces: A Strategic Tool for Navigating the Insulin Delivery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Insulin Delivery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Insulin Delivery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Insulin Delivery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Insulin Delivery Devices Market

A detailed market share analysis in the Insulin Delivery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Insulin Delivery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Insulin Delivery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Insulin Delivery Devices Market

A strategic analysis of the Insulin Delivery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Insulin Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Baxter International Inc, Becton, Dickinson and Company, Biocon Ltd., Braun Melsungen AG, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Ltd., Dr Reddy's Laboratories Ltd, Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Insulet Corporation, Johnson & Johnson, Medtronic PLC, Merck & Co., Inc., Novo Nordisk A/S, Sanofi SA, Tandem Diabetes Care, Inc., TOPAS Advanced Polymers GmbH, Ypsomed AG, and Zealand Pharma A/S.

Market Segmentation & Coverage

This research report categorizes the Insulin Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Insulin Injectors, Insulin Pens, Insulin Pumps, and Insulin Syringes.
  • Based on End-User, market is studied across Homecare and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing chronic diseases and adoption of advanced devices for insulin delivery
      • 5.1.1.2. Increasing diabetic & obese population across the globe
      • 5.1.1.3. Rising consumer awareness about the latest insulin delivery devices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of insulin delivery devices and lack of insurance coverage
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in insulin delivery devices
      • 5.1.3.2. Introduction of automated insulin delivery devices
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing stringent government rules and complicated product approval process
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Insulin Delivery Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Insulin Injectors
  • 6.3. Insulin Pens
  • 6.4. Insulin Pumps
  • 6.5. Insulin Syringes

7. Insulin Delivery Devices Market, by End-User

  • 7.1. Introduction
  • 7.2. Homecare
  • 7.3. Hospitals

8. Americas Insulin Delivery Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Insulin Delivery Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Insulin Delivery Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Baxter International Inc
  • 3. Becton, Dickinson and Company
  • 4. Biocon Ltd.
  • 5. Braun Melsungen AG
  • 6. Bristol-Myers Squibb Company
  • 7. Daiichi Sankyo Company, Ltd.
  • 8. Dr Reddy's Laboratories Ltd
  • 9. Eli Lilly and Company
  • 10. F. Hoffmann-La Roche, Ltd.
  • 11. Insulet Corporation
  • 12. Johnson & Johnson
  • 13. Medtronic PLC
  • 14. Merck & Co., Inc.
  • 15. Novo Nordisk A/S
  • 16. Sanofi SA
  • 17. Tandem Diabetes Care, Inc.
  • 18. TOPAS Advanced Polymers GmbH
  • 19. Ypsomed AG
  • 20. Zealand Pharma A/S

LIST OF FIGURES

  • FIGURE 1. INSULIN DELIVERY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. INSULIN DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. INSULIN DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. INSULIN DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INSULIN DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INSULIN DELIVERY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. INSULIN DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. INSULIN DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023